4-Methyl-2-oxopentanoic acid

CAS No. 18069-17-5

4-Methyl-2-oxopentanoic acid( —— )

Catalog No. M19852 CAS No. 18069-17-5

2-Methylglutaric acid is an organic acid normally found in human urine in healthy adults and children. It is a metabolite of succinic acid a citric acid cycle intermediate.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 49 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-Methyl-2-oxopentanoic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    2-Methylglutaric acid is an organic acid normally found in human urine in healthy adults and children. It is a metabolite of succinic acid a citric acid cycle intermediate.
  • Description
    2-Methylglutaric acid is an organic acid normally found in human urine in healthy adults and children. It is a metabolite of succinic acid a citric acid cycle intermediate.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    18069-17-5
  • Formula Weight
    146.14
  • Molecular Formula
    C6H10O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    CC(CCC(O)=O)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lefevere MF et al. Metabolic profiling of urinary organic acids by single and multicolumn capillary gas chromatography. J Chromatogr Sci. 1989 Jan;27(1):23-9.
molnova catalog
related products
  • NE 52-QQ57

    NE 52-QQ57 is a selective, and orally available antagonist of GPR4(IC50 : 70 nM),with anti-inflammatory activity.

  • Tenilsetam

    Tenilsetam is an endonuclease modulator; a nootropic agent and advanced glycation end product (AGE) inhibitor having potential for Alzheimer's disease (AD) treatment.

  • Boeravinone B

    Boeravinone B, a novel efflux pump inhibitor, apart from inhibiting the MdeA mediated efflux, also significantly inhibit the biofilm formation of S. aureus, boeravinone B may be used in combination with mupirocin for further development.